SomnoMed® is a publicly traded company (ASX:SOM) founded in 2004 in Sydney, Australia. The North American office, located in Frisco, Texas was opened in 2006 thus introducing their leading device technology to patients in America. To date there have been over 200,000 patients around the world who have been treated with SomnoDent!

Our world class devices are designed with our patients comfort top of mind and we are proud to have the longest lasting device and the best support and service system to satisfy patients, dentists, physicians and payers.

SomnoMed is making unique investments in a medical initiative to increase physician’s awareness that oral device treatment is an extremely effective method of treatment in the right patient population.  The company Is also helping to increase the collaboration between dentists and physicians, which will improve the sleep health of patients suffering from obstructive sleep apnea.